Discovering which genes may cause tumor cells to metastasize is critical to further understanding the breast cancer lifecycle and to increasing long-term survival rates.
To accelerate such understanding, the JKTG Foundation, along with the Wistar Institute, will host a full-day, scientific conference with world-renowned clinical and breast cancer research pioneers to discuss new possibilities in the diagnosis and treatment of the disease.
The symposium will be led by Frank J. Rauscher, III, Ph.D., deputy director of Wistar’s National Cancer Institute-designated Cancer Center, and feature more than a dozen leading cancer researchers.
Nobel Laureate Carol Greider, Ph.D., Johns Hopkins University, will present the inaugural Jayne Koskinas Memorial Lecture in Breast Cancer Research on “Telomeres in Cancer and Stem Cell Failure.”
Register, see the full agenda and speakers, or print out a flyer for the event by visiting the event website.
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) today announced funding to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.
The word “stakeholder” really bothers me particularly in the healthcare space. I’m struck by a quote by Ken Burns.
“The thing that I’ve learned is that there is no ‘them.’ This is what everybody does: make a distinction about ‘them.’ It’s just ‘us’.”
In racing, we measure this in lap times often down to the second or tenths of a second. A recent racing article provoked me to think about the pursuit of “the last tenth” of a second in improvement which is typically the toughest and most difficult to attain.